What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Alzheimer's disease
The scientist’s investigation covers issues in Dementia, Alzheimer's disease, Disease, Neuroscience and Psychiatry.
Bruno Dubois combines subjects such as Clinical trial, Pediatrics and Neuropsychology with his study of Dementia.
His studies deal with areas such as Cognitive decline, Audiology and Degenerative disease as well as Alzheimer's disease.
His Disease research also works with subjects such as
- Intensive care medicine, which have a strong connection to Florbetaben,
- Biomarker together with Position paper.
Within one scientific family, Bruno Dubois focuses on topics pertaining to Parkinson's disease under Neuroscience, and may sometimes address concerns connected to Severity of illness, Caudate nucleus, Physical medicine and rehabilitation and Dopamine.
Bruno Dubois interconnects Clinical psychology and Rating scale in the investigation of issues within Psychiatry.
His most cited work include:
- Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium (3883 citations)
- Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria (3224 citations)
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. (2766 citations)
What are the main themes of his work throughout his whole career to date?
Bruno Dubois focuses on Disease, Dementia, Neuroscience, Internal medicine and Cognition.
The study incorporates disciplines such as Biomarker, Clinical trial, Neuroimaging and Intensive care medicine in addition to Disease.
Degenerative disease is closely connected to Alzheimer's disease in his research, which is encompassed under the umbrella topic of Dementia.
His work on Parkinson's disease expands to the thematically related Neuroscience.
He has researched Internal medicine in several fields, including Placebo, Endocrinology, Oncology and Cardiology.
His Cognition study combines topics from a wide range of disciplines, such as Developmental psychology, Cognitive psychology and Audiology.
He most often published in these fields:
- Disease (39.72%)
- Dementia (24.01%)
- Neuroscience (24.78%)
What were the highlights of his more recent work (between 2018-2021)?
- Disease (39.72%)
- Internal medicine (26.18%)
- Dementia (24.01%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Disease, Internal medicine, Dementia, Cohort and Oncology.
His study in Disease is interdisciplinary in nature, drawing from both Biomarker, Asymptomatic and Neuroimaging, Neuroscience.
His research in Internal medicine intersects with topics in Endocrinology and Allele.
The Dementia study combines topics in areas such as Alzheimer's disease and Cognitive impairment.
He works mostly in the field of Cohort, limiting it down to topics relating to Cognition and, in certain cases, Neurology, as a part of the same area of interest.
Bruno Dubois has included themes like Precision medicine, Receiver operating characteristic and Amyloidosis in his Oncology study.
Between 2018 and 2021, his most popular works were:
- Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia (73 citations)
- Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease. (50 citations)
- Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease. (50 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cognition
Bruno Dubois mainly focuses on Disease, Cohort, Dementia, Internal medicine and Biomarker.
His work deals with themes such as Incidence, Gerontology, Cognition, Neuroscience and Intensive care medicine, which intersect with Disease.
The concepts of his Neuroscience study are interwoven with issues in Progressive supranuclear palsy, Neuropathology and Set.
He frequently studies issues relating to Alzheimer's disease and Dementia.
His Internal medicine study integrates concerns from other disciplines, such as Positron emission tomography and Oncology.
His research integrates issues of Immunology, Immune system, Immunity, Parkinson's disease and Cellular pathology in his study of Biomarker.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
